Quick Takeaways
- This page summarizes Jack E. Stover's Form 4 filing for Onconova Therapeutics, Inc. (TRAW).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 19 Aug 2022, 17:10.
Jack E. Stover - 18 Aug 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)
- Role
- Director
- Signature
- /s/ Mark Guerin, Attorney-in-Fact
- Issuer symbol
- TRAW
- Transactions as of
- 18 Aug 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 19 Aug 2022, 17:10:11 UTC
- Previous filing
- 23 Aug 2022
- Next filing
- 14 Aug 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Jack E. Stover filed Form 4 for Onconova Therapeutics, Inc. (TRAW) on 19 Aug 2022."
What Changed
- Previous filing in this sequence was filed on 23 Aug 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ONTX | Stock Option (right to purchase) | Award | $0 | +66,468 | $0.000000 | 66,468 | 18 Aug 2022 | Common Stock | 66,468 | $1.26 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | These options vest 100% on the first anniversary of the grant date. |